id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-320860-qt84oicg	Zhang, Aining	Meta-Analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19	2020-09-15		.txt	text/plain	2363	85	37	The unique characteristics of COVID-19 coagulopathy Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID Clinical features and treatment of COVID-19 patients in northeast Chongqing Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Epidemiological, clinical and virological characteristics of 74 cases of coronavirus Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Prominent changes in blood coagulation of patients with SARS-CoV-2 infection Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Conclusions Our data support the notion that coagulopathy could be considered as a risk factor for disease severity and mortality of COVID-19, which may help clinicians to identify the incidence of poor outcomes in COVID-19 patients.	cache/cord-320860-qt84oicg.txt	txt/cord-320860-qt84oicg.txt
